Back to search

Ireland· IE-PA-EU/1/26/2016/001-006

Supemtek solution for injection in pre-filled syringe Trivalent influenza vaccine (recombinant, prepared in cell culture)

A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing influenza a virus subtype h1n1 haemagglutinin, recombinant + influenza a virus subtype h3n2 haemagglutinin, recombinant + influenza b virus victoria lineage haemagglutinin, recombinant, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07BB02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSupemtek solution for injection in pr…ATCJ07BB02REGISTER NO.IE-PA-EU/1/26/2016/00…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Influenza A virus subtype H1N1 haemagglutinin, recombinant + Influenza A virus subtype H3N2 haemagglutinin, recombinant + Influenza B virus Victoria lineage haemagglutinin, recombinant
Manufacturer
Sanofi Winthrop Industrie
Country
Ireland (IE)
ATC code
J07BB02
ATC class
Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/26/2016/001-006

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/64450116-bc22-4f3b-8bb4-69136de8b5e5
GET /v1/drugs/64450116-bc22-4f3b-8bb4-69136de8b5e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07BB02"
  ],
  "strength": null,
  "pa_number": "EU/1/26/2016/001-006",
  "substances": [
    "Influenza A virus subtype H1N1 haemagglutinin, recombinant",
    "Influenza A virus subtype H3N2 haemagglutinin, recombinant",
    "Influenza B virus Victoria lineage haemagglutinin, recombinant"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "30/03/2026",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.